Ovarian Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

ReportLinker

Segmented By Diagnosis Type (Diagnostic Imaging {Transvaginal Ultrasound, CT Scan, MRI Scan, PET Scan, Others}, Blood Test {CA-125, HER2, BRCA, KRAS Mutation, Others}, Biopsy {Image Guided Biopsy, Fine Needle Aspiration Biopsy, Others}, Others), By Cancer Type (Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor, Others), By End User (Hospitals & Specialty Clinics, Ambulatory Care Centers, Others), By Region.

New York, July 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ovarian Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" - https://www.reportlinker.com/p06310355/?utm_source=GNW

The global ovarian cancer diagnostics market is projected to grow at a significant CAGR during the forecast period, 2023-2027.The market growth can be attributed to the rising demand for the early diagnosis of ovarian cancer.

Growing ovarian cancer awareness has led to increased demand for timely cancer detection, leading to global ovarian cancer diagnostics market growth.
Ovarian cancer is one of the major causes of rising mortality rates among female populations worldwide, which is fueling the growth of the global ovarian cancer diagnostics market over the next five years.Cancer in the ovaries and cysts are becoming more common due to various factors such as environmental factors and genetic mutations.

The advancement of healthcare services and improved patient care services will further support the growth of the global ovarian cancer diagnostics market in the coming years.
Cancer is a chronic disease in which tumors and cysts form in specific organs or organ sites that are abnormal and do not undergo complete cell growth before division, resulting in lumps.These cancer lumps interfere with the functioning of the organ as well as the entire human body system, thereby deteriorating the patient’s health.

Ovarian cancer is a type of cancer that affects women’s egg-producing organs, the ovaries.Ovarian cancer is difficult to diagnose because the symptoms are vague and are often detected only after cancer has spread through the stomach and pelvis, making it difficult to cure.

As a result, improved diagnostic processes and techniques are required to determine the cancer stage to treat. Furthermore, the rising mortality rate from ovarian cancer is concerning, emphasizing the importance of early detection so that treatment can be provided.
The global ovarian cancer diagnostics market is segmented based on diagnosis type, cancer type, end user, regional distribution, and competitive landscape.Based on diagnosis type, the market is further segmented into diagnostic imaging, blood test, biopsy, and others.

The diagnostic imaging segment is expected to dominate the global ovarian cancer diagnostics market on account of the increasing importance of early diagnosis and cancer staging.
Key players operating in the global ovarian cancer diagnostics market are Abbott Laboratories, Inc., Bio-Rad Laboratories, Inc., Quest Diagnostics, Inc., Siemens Healthineers AG, Thermo Fischer Scientific, Inc., F. Hoffmann-La Roche Ltd (Foundation Medicine), MiRXES Pte Ltd, GinaLife, Luminex Corporation, Myriad Genetics Inc., among others.

Years considered for this report:

Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023–2027

Objective of the Study:

• To analyze the historical growth in the market size of the global ovarian cancer diagnostics from 2017 to 2021.
• To estimate and forecast the market size of global ovarian cancer diagnostics market from 2023 to 2027 and growth rate until 2027.
• To classify and forecast the global ovarian cancer diagnostics market based on diagnosis type, cancer type, end user, region, and company.
• To identify the dominant region or segment in the global ovarian cancer diagnostics market.
• To identify drivers and challenges for the global ovarian cancer diagnostics market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global ovarian cancer diagnostics market.
• To identify and analyze the profiles of leading players operating in the global ovarian cancer diagnostics market.
• To identify key sustainable strategies adopted by market players in global ovarian cancer diagnostics market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of manufacturers across the country.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the manufacturers who could not be identified due to the limitations of secondary research. The analyst examined the manufacturers, distribution channels and presence of all major players across the country.
The analyst calculated the market size of the Global ovarian cancer diagnostics market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global ovarian cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Ovarian Cancer Diagnostics Market, By Diagnosis Type:
o Diagnostic Imaging
Transvaginal Ultrasound
CT Scan
MRI Scan
PET Scan
Others
o Blood Test
CA-125
HER2
BRCA
KRAS Mutation
Others
o Biopsy
Image Guided Biopsy
Fine Needle Aspiration Biopsy
Others
o Others
• Ovarian Cancer Diagnostics Market, By Cancer Type:
o Epithelial Tumor
o Germ Cell Tumor
o Stromal Cell Tumor
o Others
• Ovarian Cancer Diagnostics Market, By End User:
o Hospitals & Specialty Clinics
o Ambulatory Care Centers
o Others
• Ovarian Cancer Diagnostics Market, By Region:
o North America
United States
Mexico
Canada
o Asia-Pacific
China
India
Japan
South Korea
Australia
o Europe
France
Germany
United Kingdom
Spain
Italy
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global ovarian cancer diagnostics market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).
Read the full report: https://www.reportlinker.com/p06310355/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001